Overview


A synthetic drug is a chemical compound that is synthesized in a laboratory. Rather than using natural ingredients, these drugs are made from man-made chemicals. Pharmaceutical companies produce synthetic drugs for commercial purposes for valid medical reasons and divert them from legal channels. The purpose of these drugs is primarily to mimic the properties of existing illegitimate drugs, such as cocaine, cannabis, and ecstasy. In order to be marketed as authorized, safe and suitable alternatives to illicit drugs, they have a different chemical construction from illegal substances. In developed regions, pharmacotherapies are helping the synthetic drugs market grow at a rapid pace due to the growing popularity of synthetic drugs. Synthetic drugs are increasingly being used in the treatment of pain and neurological disorders, which is contributing to the growth of the market for synthetic drugs. Furthermore, the development of a string of pipeline projects substantial growth opportunities in the synthetic drugs market. It is however important to note that the regulatory scenario across various regions plays a major role in determining the market's demand and growth potential.

Various developments in the synthetic drugs market are further driving demand for synthetic drugs and offering great opportunities for manufacturers operating in the market. The goal of synthetic drug manufacturers is to acquire companies that will provide substantial growth opportunities. These acquisitions allow manufacturers in the market to expand their product offerings for consumers, nutraceuticals, and pharmaceuticals. Through its trademarked technology platforms, Lygos can produce superior quality, sustainable, and excellent cannabinoids and quickly commercialize innovative cannabinoid-based nutraceuticals, consumer products, and pharmaceuticals. There will be an increase in synthetic drug demand during the forecast period as a result of these developments in the global synthetic drug market.

Synthetic drugs market growth will be further boosted by the introduction of innovative techniques during the forecast period. Moreover, the growth in research and development activities and the emergence of new markets will provide beneficial opportunities for the synthetic drugs market. The high cost of treatment and the side effects associated with synthetic drugs, such as aggression, anxiety, seizures, paranoia, nausea, loss of consciousness, vomiting and coma, will hinder the market's growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Synthetic Drugs Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Synthetic Drugs Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Mylan N.V.
  • Noramco
  • Lygos, Inc.
  • Hyasynth Biologicals, Inc.
  • Alkem Labs
  • Renew Biopharma
  • KBL Merger Corp. IV
  • Ginkgo Bioworks
  • Emerald Health Pharmaceuticals
  • CB Therapeutics, Inc.
  • Insys Therapeutics, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Enabling Products
  • DNA Synthesis
  • Oligonucleotide Synthesis
  • Enabled Products
  • Pharmaceuticals
  • Chemical
  • Biofuels
  • Agriculture
  • Core Products
  • Synthetic DNA
  • Synthetic genes
  • Synthetic Cells
  • XNA
  • Chassis Oragnisgms

By Technology

  • Enabling Technology
  • Genome Engineering
  • Microfluids technologies
  • DNA Synthesis and Sequencing Technologies
  • Bioinformatics Technologies
  • Biological components and integrated systems technologies
  • Enabled Technology
  • Pathway Engineering
  • Synthetic Microbial Consortia
  • Biofuels Technologies

By Application

  • Research and Development
  • Cemicals
  • Agriculture
  • Pharmaceuticals and Diagnostics
  • Biofuels
  • Environment
  • Biotechnology
  • Biomaterials
  • Others

By End User

  • Hospitals
  • Pharmacy Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Synthetic Drugs Market By Product, By Technology, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Synthetic Drugs Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Synthetic Drugs Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Synthetic Drugs Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Synthetic Drugs Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Enabling Products
        2. DNA Synthesis
        3. Oligonucleotide Synthesis
        4. Enabled Products
        5. Pharmaceuticals
        6. Chemical
        7. Biofuels
        8. Agriculture
        9. Core Products
        10. Synthetic DNA
        11. Synthetic genes
        12. Synthetic Cells
        13. XNA
        14. Chassis Oragnisgms

  • 8.   Synthetic Drugs Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Enabling Technology
        2. Genome Engineering
        3. Microfluids technologies
        4. DNA Synthesis and Sequencing Technologies
        5. Bioinformatics Technologies
        6. Biological components and integrated systems technologies
        7. Enabled Technology
        8. Pathway Engineering
        9. Synthetic Microbial Consortia
        10. Biofuels Technologies

  • 9.   Synthetic Drugs Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research and Development
        2. Cemicals
        3. Agriculture
        4. Pharmaceuticals and Diagnostics
        5. Biofuels
        6. Environment
        7. Biotechnology
        8. Biomaterials
        9. Others

  • 10.   Synthetic Drugs Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Pharmacy Clinics
        3. Others

  • 11.   North America Synthetic Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Synthetic Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Synthetic Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Synthetic Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Mylan N.V.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Noramco
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Lygos, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hyasynth Biologicals, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Alkem Labs
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Renew Biopharma
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. KBL Merger Corp. IV
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ginkgo Bioworks
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Emerald Health Pharmaceuticals
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. CB Therapeutics, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Insys Therapeutics, Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients